(-0.02%) 5 221.42 points
(-0.21%) 39 432 points
(0.29%) 16 388 points
(0.09%) $79.19
(-0.29%) $2.37
(0.02%) $2 343.50
(0.13%) $28.48
(0.07%) $1 011.50
(-0.18%) $0.927
(-0.15%) $10.82
(-0.28%) $0.796
(-1.16%) $91.60
Live Chart Being Loaded With Signals
NATCO Pharma Limited, a pharmaceutical company, develops, manufactures, and markets finished dosage formulations and active pharmaceutical ingredients (APIs)...
Stats | |
---|---|
Today's Volume | 686 887 |
Average Volume | 1.07M |
Market Cap | 174.54B |
EPS | INR0 ( 2024-02-13 ) |
Next earnings date | ( INR0 ) 2024-05-27 |
Last Dividend | INR7.00 ( 2023-08-22 ) |
Next Dividend | INR0 ( N/A ) |
P/E | 13.74 |
ATR14 | INR0.485 (0.05%) |
Volume Correlation
NATCO Pharma Limited Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
NATCO Pharma Limited Correlation - Currency/Commodity
NATCO Pharma Limited Financials
Annual | 2022 |
Revenue: | INR27.07B |
Gross Profit: | INR20.80B (76.83 %) |
EPS: | INR39.18 |
FY | 2022 |
Revenue: | INR27.07B |
Gross Profit: | INR20.80B (76.83 %) |
EPS: | INR39.18 |
FY | 2022 |
Revenue: | INR19.05B |
Gross Profit: | INR12.23B (64.22 %) |
EPS: | INR9.32 |
FY | 2021 |
Revenue: | INR16.90B |
Gross Profit: | INR10.82B (64.04 %) |
EPS: | INR24.20 |
Financial Reports:
No articles found.
NATCO Pharma Limited Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
INR3.50 (N/A) |
INR0.750 (N/A) |
INR1.250 (N/A) |
INR0 (N/A) |
INR7.00 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | INR0.200 | 1996-12-31 |
Last Dividend | INR7.00 | 2023-08-22 |
Next Dividend | INR0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 33 | -- |
Total Paid Out | INR56.90 | -- |
Avg. Dividend % Per Year | 0.68% | -- |
Score | 2.39 | -- |
Div. Sustainability Score | 1.998 | |
Div.Growth Potential Score | 3.28 | |
Div. Directional Score | 2.64 | -- |
Year | Amount | Yield |
---|---|---|
1996 | INR0 | 0.00% |
1997 | INR0 | 0.00% |
1998 | INR0 | 0.00% |
1999 | INR0 | 0.00% |
2000 | INR0 | 0.00% |
2001 | INR0 | 0.00% |
2002 | INR0 | 0.00% |
2003 | INR0 | 0.00% |
2004 | INR0 | 0.00% |
2005 | INR0 | 0.00% |
2006 | INR0 | 0.00% |
2007 | INR0 | 0.00% |
2008 | INR0 | 0.00% |
2009 | INR0 | 0.00% |
2010 | INR0 | 0.00% |
2011 | INR0 | 0.00% |
2012 | INR0 | 0.00% |
2013 | INR0 | 0.00% |
2014 | INR0 | 0.00% |
2015 | INR0 | 0.00% |
2016 | INR0 | 0.00% |
2017 | INR0 | 0.00% |
2018 | INR8.50 | 1.07% |
2019 | INR7.00 | 1.01% |
2020 | INR8.75 | 1.42% |
2021 | INR3.50 | 0.36% |
2022 | INR6.25 | 0.68% |
2023 | INR8.25 | 1.49% |
2024 | INR0 | 0.00% |
The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
KABRAEXTRU.NS | Dividend Knight | 2023-07-13 | Annually | 23 | 0.83% | |
DTIL.NS | Dividend Junior | 2023-09-12 | Annually | 10 | 0.98% | |
ACE.NS | Dividend Junior | 2023-08-17 | Annually | 18 | 0.23% | |
STERTOOLS.NS | Dividend Junior | 2023-09-11 | Annually | 19 | 0.38% | |
MURUDCERA.NS | Dividend Junior | 2023-09-14 | Sporadic | 21 | 0.33% | |
HIL.NS | Dividend Knight | 2023-07-21 | Semi-Annually | 20 | 1.17% | |
BLUESTARCO.NS | Dividend Knight | 2023-07-21 | Annually | 22 | 0.96% | |
REMSONSIND.NS | Dividend Junior | 2023-09-08 | Sporadic | 22 | 0.51% | |
KRISHANA.NS | Dividend Junior | 2023-09-21 | Annually | 6 | 0.46% | |
FAIRCHEMOR.NS | Dividend Junior | 2023-07-31 | Annually | 4 | 0.38% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.334 | 1.500 | 3.32 | 4.99 | [0 - 0.5] |
returnOnAssetsTTM | 0 | 1.200 | 0 | 0 | [0 - 0.3] |
returnOnEquityTTM | 0.251 | 1.500 | 8.32 | 10.00 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 0 | 0.800 | -5.00 | -4.00 | [1 - 3] |
quickRatioTTM | 0 | 0.800 | -4.71 | -3.76 | [0.8 - 2.5] |
cashRatioTTM | 0 | 1.500 | -1.111 | -1.667 | [0.2 - 2] |
debtRatioTTM | 0 | -1.500 | 0 | 0 | [0 - 0.6] |
interestCoverageTTM | 97.83 | 1.000 | 10.00 | 10.00 | [3 - 30] |
operatingCashFlowPerShareTTM | 19.24 | 2.00 | 3.59 | 7.17 | [0 - 30] |
freeCashFlowPerShareTTM | 19.24 | 2.00 | 0.380 | 0.760 | [0 - 20] |
debtEquityRatioTTM | 0 | -1.500 | 0 | 0 | [0 - 2.5] |
grossProfitMarginTTM | 0.783 | 1.000 | 0.290 | 0.290 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.401 | 1.000 | 3.98 | 3.98 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0 | 1.000 | -1.111 | -1.111 | [0.2 - 2] |
assetTurnoverTTM | 0 | 0.800 | -3.33 | -2.67 | [0.5 - 2] |
Total Score | 1.998 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 13.88 | 1.000 | 8.70 | 0 | [1 - 100] |
returnOnEquityTTM | 0.251 | 2.50 | 8.92 | 10.00 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 19.24 | 2.00 | 3.59 | 0.760 | [0 - 30] |
dividendYielPercentageTTM | 0.959 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 19.24 | 2.00 | 3.59 | 7.17 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | -3.11 | 1.500 | -10.00 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.0900 | 1.000 | -0.250 | 0 | [0.1 - 0.5] |
Total Score | 3.28 |
NATCO Pharma Limited
NATCO Pharma Limited, a pharmaceutical company, develops, manufactures, and markets finished dosage formulations and active pharmaceutical ingredients (APIs). It offers formulations in various therapeutic areas, including cancers of blood, liver, kidney, lung, brain, breast, ovary, etc.; and APIs in various categories, such as oncology, central nervous system, pain management, and CV care. The company also offers orthopedic products comprising bisphosphonates, which are oral and injectable drugs; and gastroenterology products consisting of novel drugs for chronic hepatitis-B and hepatitis-C, as well as contract manufacturing services. In addition, it provides cardiology and diabetology products for the treatment of hypertension, stable angina and CHF. The company markets its products in approximately 40 countries, including India, the United States, and internationally. NATCO Pharma Limited was incorporated in 1981 and is headquartered in Hyderabad, India.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators